Agenda
|
||
8:00 – 8:30 |
**Registration** |
|
8:30 – 8:50 |
Welcome and Workshop Overview Natalia Kruchinin, Ph.D., NIAID Small Business Program Coordinator, Office of Research Training and Special Programs, Division of Extramural Activities, NIAID Beena Koshy, Ph.D., Assistant Vice Chancellor for Innovation & Industry Relations, Office of Technology Commercialization, The University of Texas System Andrea Giuffrida, Ph.D., Vice President for Research, University of Texas Health Science Center at San Antonio Bernard Arulanandam, Ph.D., M.B.A., Interim Vice President for Research, University of Texas at San Antonio |
|
8:50 – 9:50 |
Overview of the NIH SBIR/STTR Programs Matthew E. Portnoy, Ph.D., SBIR/STTR Director, Division of Special Programs / NIH SBIR/STTR Program Manager, Office of Extramural Programs, Office of Extramural Research, NIH |
|
9:50 – 10:20 |
Scientific Review at NIH Amy Rubinstein, Ph.D., Scientific Review Officer, Point Person for Review of Small Business Applications, Center for Scientific Review, NIH |
|
10:20 – 10:30 |
**Break** |
|
10:30 – 11:00 |
SBIR/STTR Program Integrity Maritza E. Zeiberg, C.P.A., Director, Division of Program Integrity, Office of Management Assessment, Office of the Director, NIH |
|
11:00 – 11:30 |
Grants Management Dhana Khurana, M.B.A., Lead Grants Management Specialist, Division of Extramural Activities, NIAID |
|
11:30 – 12:00 |
Funding Landscape for Early-Stage Companies Matthew Fenton, Ph.D., Director, Division of Extramural Activities, NIAID |
|
12:00 – 1:00 |
**Break** |
|
1:00 – 1:50 |
SBIR/STTR Program at NIAID & High-Priority Areas of Interest Natalia Kruchinin, Ph.D., NIAID Small Business Program Coordinator, Office of Research Training and Special Programs, Division of Extramural Activities, NIAID Michael Minnicozzi, Ph.D., Senior Program Officer, Allergy, Asthma and Airways Biology Branch, Division of Allergy, Immunology and Transplantation, NIAID |
|
1:50 – 2:20 |
SBIR/STTR Program at National Cancer Institute Kory Hallett, Ph.D., AAAS Science & Technology Policy Fellow, SBIR Development Center, NCI |
|
2:20 – 2:50 |
SBIR/STTR Program at National Institute of General Medical Sciences Scott Somers, Ph.D., Program Director, Division of Pharmacology, Physiology, and Biological Chemistry, NIGMS |
|
2:50 – 3:20 |
SBIR/STTR Program at National Institute of Biomedical Imaging and Bioengineering (NIBIB)- Small Business Support for Medical Device Development Mr. Todd Merchak, Biomedical Engineer, NIBIB |
|
3:20 – 3:30 |
**Break** |
|
3:30-4:00 |
The March toward a Licensed PfSPZ Malaria Vaccine: A Journey Made Possible by SBIRs Stephen L. Hoffman, M.D., D.T.M.H., D.Sc. (hon), FASTMH, CAPT, MC, USN (RET), Chief Executive and Scientific Officer, Sanaria, Inc. |
|
4:00 – 4:30 |
Writing a Competitive SBIR/STTR Phase I Application Lisa M. Kurek, M.S., Managing Partner, BBC Entrepreneurial Training & Consulting, LLC |
|
4:30 – 5:30 |
One-on-One Meetings with Government Staff NIAID, NIGMS, NCI, NIBIB representatives |
|
|
||
8:30 – 9:00 |
**Registration** |
|
9:00 – 9:50 |
The Path from Discovery to Market Andrey J. Zarur, Ph.D., Managing General Partner, Kodiak Venture Partners |
|
9:50 – 10:40 |
SBIR-Funded Product: Development, Validation, Launch David Beylin, M.S., M.B.A., CEO, BLN Scientific, LLC |
|
10:40 – 11:30 |
How to Pitch Your Business to Investors? Liddy Karter, M.B.A., Managing Director, Enhanced Capital Partners |
|
11:30 – 11:40 |
**Break** |
|
11:40-12:40 |
Panel: Diversifying NIH’s SBIR/STTR Program Moderator: Diane Adger-Johnson, Health Science Program Officer, ORTSP, DEA, NIAID Panel members: Matthew E. Portnoy, Ph.D., NIH SBIR/STTR Program Coordinator David Beylin, M.S., M.B.A., CEO, BLN Scientific, LLC Kory Hallett, Ph.D., AAAS Science & Technology Policy Fellow, SBIR Development Center, NCI TBD |
|
12:40-1:40 |
**Break** |
|
1:40 – 2:30 |
Writing a Competitive SBIR/STTR Phase II Application Lisa M. Kurek, M.S., Managing Partner, BBC Entrepreneurial Training & Consulting, LLC |
|
2:30-3:00 |
Lessons Learned – Invest Your Time Wisely - by Yaso Biotechnology, Inc. Mary F. Weitzel, M.B.A., CEO and President, Yaso Biotechnology, Inc. |
|
3:00-3:20 |
Connecting the SBIR/STTR and I-Corps Programs to Achieve Commercialization Success across The University of Texas System Carlos A. Kemeny, Ph.D., M.B.A. Assistant Director, Office of Technology Commercialization, The University of Texas System |
|
3:20-3:50 |
Alafair Biosciences: A Bench to Bedside Story Made Possible with Non-Dilutive Funding Sarah Mayes, Ph.D., Director of R&D, Alafair Biosciences, Inc. |
|
3:50-4:00 |
Wrap-up and Closing Remarks Natalia Kruchinin, Ph.D., NIAID Small Business Program Coordinator, Office of Research Training and Special Programs, Division of Extramural Activities, NIAID Beena Koshy, Ph.D., Assistant Vice Chancellor for Innovation & Industry Relations, Office of Technology Commercialization, The University of Texas System |